EREG

EREG

EREG Informations sur la molécule

Molecule Name
Epiregulin
Alias de la molécule
EPR, ER, Ep
Drug Development Progress
Nombre de médicaments cliniques2
Nombre de médicaments commercialisés0
Phase de R&D la plus avancéePhase 2 Clinical
Alias de la cible
Epiregulin,Ep,EREG,EPR,ER,Proepiregulin
Contexte de la molécule
EREG is a ligand of the epidermal growth factor receptor (EGFR) and the structurally related erb-b2 receptor tyrosine kinase 4 (ERBB4), which stimulates tyrosine phosphorylation of EGFR and ERBB4. EREG may be involved in a wide range of biological processes including inflammation, wound healing, oocyte maturation, and cell proliferation. Additionally, EREG may promote the progression of cancers of various human tissue.

EREG Liste de produits

Species
  • Human(1)
Tag
  • Fc Tag(1)
Host
  • HEK293(1)
Conjugate
  • Unconjugated(1)
Grade
  • RUO(1)
Low Endotoxin
  • No(1)
MoleculeCat. No.Product NameEspèceHostStructurePurityActivitySize&PriceAdd to Cart
EREG
Human EREG Protein, Fc Tag
Human
HEK293
SDS-PAGE

$395.00

100ug
You Have Viewed 1-1 Of 1 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
FepixnebartLY-3016859Phase 2 ClinicalEli Lilly And Company
Diabetic Nephropathies; Diabetic Neuropathies; Low Back Pain; Osteoarthritis; Osteoarthritis, Knee
Details
Epiregulin AntibodyLY3848575; LY-3848575Phase 2 ClinicalEli Lilly And Company
Neuralgia; Polyneuropathies
Details
Customer Reviews